D

Dr.Umesh Laddi's Med-Chemist

Do regularly update on FDA approvals, clinical trials, new
drugs, side effects, drug discovery, synthetic chemistry,
med, chemist,

  • Rated2.4/ 5
  • Updated 1 Year Ago

U.S. FDA Grants Priority Review for Fedratinib New Drug Application in Myelofibrosis

Updated 5 Years Ago

U.S. FDA Grants Priority Review For Fedratinib New Drug Application In Myelofibrosis
Celgene Corporation (NASDAQ:CELG)   announced the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application ...
Read More